Jiro Kitaura

Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells.

Hideaki Nakajima, Fumi Shibata, S. Yamazaki, 2008, Blood.

Identification of RHOXF2 (PEPP2) as a cancer-promoting gene by expression cloning.

Fumio Nakahara, Junya Fukuoka, S. Kageyama, 2011, International journal of oncology.

SETBP1 Mutations Drive Leukemic Transformation in ASXL1-Mutated MDS

Omar Abdel-Wahab, Hironori Harada, Daichi Inoue, 2014, Leukemia.

Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI

Toshiaki Kawakami, Stephen J. Galli, B. George Barisas, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Possible involvement of RasGRP4 in leukemogenesis

Hironori Harada, Hideaki Nakajima, Ryoichi Ono, 2009, International journal of hematology.

An Activating and Inhibitory Signal from an Inhibitory Receptor LMIR3/CLM-1: LMIR3 Augments Lipopolysaccharide Response through Association with FcRγ in Mast Cells1

Yutaka Enomoto, T. Kitamura, T. Takai, 2009, The Journal of Immunology.

Characterization of Leukocyte Mono-immunoglobulin-like Receptor 7 (LMIR7)/CLM-3 as an Activating Receptor

Yutaka Enomoto, T. Kitamura, T. Takai, 2010, The Journal of Biological Chemistry.

Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.

Hiroaki Honda, Hideaki Oda, Takuro Nakamura, 2009, Blood.

Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models.

Fumio Nakahara, Hironori Harada, Hideaki Nakajima, 2011, Blood.

Functional Analysis of Activating Receptor LMIR4 as a Counterpart of Inhibitory Receptor LMIR3*

Victor L. J. Tybulewicz, Hideaki Nakajima, Fumi Shibata, 2007, Journal of Biological Chemistry.